Clinical trial
A Prospective, Randomized, Multicenter Study To Compare The Safety And Effectiveness Of The OMNI® Surgical System And The iStent Inject In Pseudophakic Eyes With Open Angle Glaucoma. The TRIDENT European Trial
NCT04658095 is registered in ClinicalTrials.gov with Sight Sciences, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Multicenter Study To Compare The Safety And Effectiveness Of The OMNI® Surgical System And The iStent Inject In Pseudophakic Eyes With Open Angle Glaucoma. The TRIDENT European Trial
- Lead sponsor
- Sight Sciences, Inc.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 11, 2022
- Completion date
- November 18, 2022
- Enrollment
- 10 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.